ROCKVILLE, Md. -- Type 2 diabetes drugs aiming to pass FDA muster should be required to consider long-term cardiovascular safety as part of the approval mix, according to agency advisers.
FDA Advisers Call for Cardiovascular-Safety Assessment of New Di...Courtesy MedPage Today Infectious Disease Thu, 07/03/2008 - 10:37
ROCKVILLE, Md. -- Type 2 diabetes drugs aiming to pass FDA muster should be required to consider long-term cardiovascular safety as part of the approval mix, according to agency advisers. More related itemsStudy suggests possible link between two Type 2...
Bariatric Surgery Resolves Diabetes, Saves Money...
Study: Diet Can Help Avoid Diabetes Drugs
|
Popular by tags WeekMonth |
Post new comment